ArticleCancer medicine2020

Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients.

Takashi Matsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.